BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Back to All Ratios
|
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Last 5 Year EBIT Margin History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EBIT Margin(%) | -34.09 | -5.21 | -22.76 | -14.14 | -6.42 |
What is the latest EBIT Margin ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION ?
Year | EBIT Margin |
---|---|
Mar2023 | -34.09 |
Mar2022 | -5.21 |
Mar2021 | -22.76 |
Mar2020 | -14.14 |
Mar2019 | -6.42 |
How is EBIT Margin of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Trending?
Years | EBIT Margin | % Change | |
---|---|---|---|
Mar2023 | -34.09 | Negative | |
Mar2022 | -5.21 | Negative | |
Mar2021 | -22.76 | Negative | |
Mar2020 | -14.14 | Negative | |
Mar2019 | -6.42 | - |
Other Financial Ratios of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EBIT Margin ratio of peers of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | ₹98.3 Cr | -9.7% | -7.7% | -33.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,363.0 Cr | -2.8% | -3.6% | 10.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,396.0 Cr | -2.5% | 1.5% | 59.1% | Stock Analytics | |
CIPLA | ₹117,088.0 Cr | -1.5% | 0.2% | 1.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,458.0 Cr | -1.6% | -9.2% | -4.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,002.4 Cr | -7.4% | -5.1% | 9.9% | Stock Analytics |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | -9.7% |
-7.7% |
-33.9% |
SENSEX | -2.7% |
-0.4% |
6.4% |
You may also like the below Video Courses